Coexpression cluster:C462
From FANTOM5_SSTAR
Full id: C462_CD14_Monocytederived_Macrophage_Hepatic_Dendritic_lung_adipose
Phase1 CAGE Peaks
Hg19::chr10:49860525..49860564,- | p7@ARHGAP22 |
Hg19::chr14:61448920..61448942,+ | p4@SLC38A6 |
Hg19::chr14:93118883..93118894,+ | p25@RIN3 |
Hg19::chr14:93214988..93215002,- | p2@LGMN |
Hg19::chr17:29281231..29281262,+ | p3@ADAP2 |
Hg19::chr17:29290132..29290136,+ | p@chr17:29290132..29290136 + |
Hg19::chr17:29297900..29297936,- | p2@AK092436 |
Hg19::chr17:7462347..7462356,+ | p10@TNFSF13 |
Hg19::chr19:11688452..11688486,- | p1@ACP5 |
Hg19::chr19:12992244..12992272,- | p2@DNASE2 |
Hg19::chr19:40872251..40872269,+ | p25@PLD3 |
Hg19::chr19:51645742..51645787,+ | p1@SIGLEC7 |
Hg19::chr1:159796513..159796524,+ | p7@SLAMF8 |
Hg19::chr1:206945673..206945712,- | p4@IL10 |
Hg19::chr1:22965767..22965778,+ | p@chr1:22965767..22965778 + |
Hg19::chr20:43990576..43990596,+ | p4@SYS1 |
Hg19::chr20:48884002..48884088,+ | p1@ENST00000425497 p1@ENST00000445003 p1@uc010zyr.1 |
Hg19::chr22:27014043..27014073,- | p2@CRYBB1 |
Hg19::chr22:47016102..47016117,+ | p2@GRAMD4 |
Hg19::chr2:232106599..232106613,- | p@chr2:232106599..232106613 - |
Hg19::chr5:76383909..76383944,+ | p1@ENST00000514288 |
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
p.value | FDR | nGenes | nPathway | Name |
---|---|---|---|---|
3.25661910109795e-05 | 0.02061439890995 | 3 | 121 | Lysosome (KEGG):04142 |
Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data
GO ID | GO name | FDR corrected p-value |
---|---|---|
GO:0005764 | lysosome | 0.00929741119260226 |
GO:0000323 | lytic vacuole | 0.00929741119260226 |
GO:0005773 | vacuole | 0.00946609524320958 |
GO:0030886 | negative regulation of myeloid dendritic cell activation | 0.0179307328724496 |
GO:0045355 | negative regulation of interferon-alpha biosynthetic process | 0.0179307328724496 |
GO:0005141 | interleukin-10 receptor binding | 0.0179307328724496 |
GO:0032695 | negative regulation of interleukin-12 production | 0.0179307328724496 |
GO:0045347 | negative regulation of MHC class II biosynthetic process | 0.0228169020854112 |
GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters | 0.0228169020854112 |
GO:0004531 | deoxyribonuclease II activity | 0.0228169020854112 |
GO:0030885 | regulation of myeloid dendritic cell activation | 0.0228169020854112 |
GO:0032655 | regulation of interleukin-12 production | 0.0313510836916462 |
GO:0007253 | cytoplasmic sequestering of NF-kappaB | 0.0313510836916462 |
GO:0001773 | myeloid dendritic cell activation | 0.0313510836916462 |
GO:0042347 | negative regulation of NF-kappaB import into nucleus | 0.0313510836916462 |
GO:0045348 | positive regulation of MHC class II biosynthetic process | 0.0313510836916462 |
GO:0045354 | regulation of interferon-alpha biosynthetic process | 0.0313510836916462 |
GO:0032607 | interferon-alpha production | 0.0313510836916462 |
GO:0045349 | interferon-alpha biosynthetic process | 0.0313510836916462 |
GO:0045342 | MHC class II biosynthetic process | 0.0313510836916462 |
GO:0045346 | regulation of MHC class II biosynthetic process | 0.0313510836916462 |
GO:0004630 | phospholipase D activity | 0.0313510836916462 |
GO:0032615 | interleukin-12 production | 0.0313510836916462 |
GO:0001509 | legumain activity | 0.0313510836916462 |
GO:0042130 | negative regulation of T cell proliferation | 0.0328150059188141 |
GO:0045351 | interferon type I biosynthetic process | 0.0328150059188141 |
GO:0032606 | interferon type I production | 0.0328150059188141 |
GO:0042994 | cytoplasmic sequestering of transcription factor | 0.0328150059188141 |
GO:0045191 | regulation of isotype switching | 0.0328150059188141 |
GO:0042092 | T-helper 2 type immune response | 0.0328150059188141 |
GO:0051220 | cytoplasmic sequestering of protein | 0.0328150059188141 |
GO:0002237 | response to molecule of bacterial origin | 0.0328150059188141 |
GO:0001818 | negative regulation of cytokine production | 0.0328150059188141 |
GO:0002208 | somatic diversification of immunoglobulins during immune response | 0.0328150059188141 |
GO:0002381 | immunoglobulin production during immune response | 0.0328150059188141 |
GO:0050868 | negative regulation of T cell activation | 0.0328150059188141 |
GO:0042308 | negative regulation of protein import into nucleus | 0.0328150059188141 |
GO:0042992 | negative regulation of transcription factor import into nucleus | 0.0328150059188141 |
GO:0050672 | negative regulation of lymphocyte proliferation | 0.0328150059188141 |
GO:0002204 | somatic recombination of immunoglobulin genes during immune response | 0.0328150059188141 |
GO:0045190 | isotype switching | 0.0328150059188141 |
GO:0032945 | negative regulation of mononuclear cell proliferation | 0.0328150059188141 |
GO:0042348 | NF-kappaB import into nucleus | 0.033405743502606 |
GO:0046823 | negative regulation of nucleocytoplasmic transport | 0.033405743502606 |
GO:0042345 | regulation of NF-kappaB import into nucleus | 0.033405743502606 |
GO:0016447 | somatic recombination of immunoglobulin gene segments | 0.0346434571716005 |
GO:0051224 | negative regulation of protein transport | 0.0346434571716005 |
GO:0016444 | somatic cell DNA recombination | 0.0375615612892389 |
GO:0016445 | somatic diversification of immunoglobulins | 0.0375615612892389 |
GO:0002562 | somatic diversification of immune receptors via germline recombination within a single locus | 0.0375615612892389 |
GO:0002200 | somatic diversification of immune receptors | 0.0385178777119114 |
GO:0042036 | negative regulation of cytokine biosynthetic process | 0.0385178777119114 |
GO:0002377 | immunoglobulin production | 0.0417129711359742 |
GO:0042100 | B cell proliferation | 0.0417129711359742 |
GO:0051250 | negative regulation of lymphocyte activation | 0.0432221762489413 |
GO:0005096 | GTPase activator activity | 0.0443656361163416 |
GO:0042990 | regulation of transcription factor import into nucleus | 0.0445173893930843 |
GO:0042991 | transcription factor import into nucleus | 0.0445173893930843 |
GO:0005212 | structural constituent of eye lens | 0.0445173893930843 |
GO:0042306 | regulation of protein import into nucleus | 0.0451002136213308 |
GO:0033157 | regulation of intracellular protein transport | 0.0451002136213308 |
GO:0016788 | hydrolase activity, acting on ester bonds | 0.0453904386158153 |
GO:0030595 | leukocyte chemotaxis | 0.0456453341420361 |
GO:0032507 | maintenance of cellular protein localization | 0.046635970718298 |
GO:0051651 | maintenance of cellular localization | 0.046635970718298 |
GO:0050864 | regulation of B cell activation | 0.046635970718298 |
GO:0032386 | regulation of intracellular transport | 0.046635970718298 |
GO:0045185 | maintenance of protein localization | 0.047779721085016 |
GO:0002440 | production of molecular mediator of immune response | 0.0481912578546151 |
GO:0002274 | myeloid leukocyte activation | 0.0481912578546151 |
GO:0051223 | regulation of protein transport | 0.0492635366268128 |
GO:0046822 | regulation of nucleocytoplasmic transport | 0.0496163041105543 |
GO:0030183 | B cell differentiation | 0.0496163041105543 |
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>
Ontology term | p-value | n |
---|---|---|
monopoietic cell | 2.97e-30 | 63 |
monocyte | 2.97e-30 | 63 |
monoblast | 2.97e-30 | 63 |
promonocyte | 2.97e-30 | 63 |
macrophage dendritic cell progenitor | 7.31e-30 | 65 |
granulocyte monocyte progenitor cell | 7.00e-27 | 71 |
CD14-positive, CD16-negative classical monocyte | 4.13e-25 | 42 |
myeloid lineage restricted progenitor cell | 5.40e-25 | 70 |
myeloid leukocyte | 8.28e-25 | 76 |
classical monocyte | 2.51e-23 | 45 |
myeloid cell | 4.60e-14 | 112 |
common myeloid progenitor | 4.60e-14 | 112 |
Ontology term | p-value | n |
---|---|---|
hematopoietic system | 8.05e-26 | 102 |
blood island | 8.05e-26 | 102 |
bone marrow | 6.15e-25 | 80 |
hemolymphoid system | 1.13e-24 | 112 |
bone element | 3.09e-23 | 86 |
immune system | 7.57e-22 | 115 |
skeletal element | 2.26e-19 | 101 |
skeletal system | 2.26e-19 | 101 |
adult organism | 2.57e-19 | 115 |
organ | 9.88e-16 | 511 |
multi-cellular organism | 3.54e-14 | 659 |
anatomical group | 5.41e-13 | 626 |
anatomical system | 7.88e-13 | 625 |
embryo | 4.67e-11 | 612 |
lateral plate mesoderm | 8.56e-11 | 216 |
embryonic structure | 4.41e-10 | 605 |
developing anatomical structure | 4.41e-10 | 605 |
germ layer | 6.01e-10 | 604 |
embryonic tissue | 6.01e-10 | 604 |
presumptive structure | 6.01e-10 | 604 |
epiblast (generic) | 6.01e-10 | 604 |
musculoskeletal system | 9.05e-09 | 167 |
mesoderm | 4.72e-08 | 448 |
mesoderm-derived structure | 4.72e-08 | 448 |
presumptive mesoderm | 4.72e-08 | 448 |
Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
Motifs | -log10(p-value) |
---|---|
{{{tfbs_overrepresentation_jaspar}}} |
ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data
No analysis results for this cluster
Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data
This analysis result is provided for C0 - C305 clusters.